Trump Moves to Fast-Track Psychedelic Drug Treatments

What Happened?

President Trump signed an executive order directing the FDA to accelerate its review of psychedelic drugs, with a specific focus on ibogaine. The substance, derived from a plant native to Central Africa, has drawn attention from researchers and veterans’ groups who believe it may help treat post-traumatic stress disorder and addiction.

The order also sets aside $50 million in federal funding for research into ibogaine and similar treatments. Officials say the goal is to shorten the timeline for clinical trials and regulatory decisions, which typically takes years. If the drugs meet safety and effectiveness standards, they could eventually be reclassified, making them legal for medical use.

The announcement was backed by figures like Robert F. Kennedy Jr. and Joe Rogan, both of whom have publicly supported expanded access to psychedelics. Texas is also positioned to benefit early, having already committed state funding to ibogaine research and infrastructure.

Why It Matters

The executive order may be ushering in a change in how the federal government approaches drugs that have long been treated primarily as illegal substances rather than potential medical tools. Psychedelics like ibogaine have been studied for years in smaller settings, but regulatory barriers have limited large-scale trials and widespread use.

When Starlink goes global - one Potential IPO
play wins big

When Starlink completes its global takeover…

It's set to connect 3 billion people who've never had reliable internet.

That's the biggest connectivity explosion in human history.

Wall Street is focused on SpaceX.

But the smartest money is looking at a backdoor play almost no one's talking about.

A Potential IPO company already positioned to profit from every single new Starlink user — in 170 countries — before they ever go public.

And if you act fast, you can invest now at $0.50/share.

Click here for the full details

But don't wait.

Their last round sold out with 59,000+ total investors. Once word spreads — it could be too late.*

Click here before this round closes.

Supporters argue that speeding up the approval process could open new treatment options for conditions that are difficult to manage with existing therapies. Veterans’ groups, in particular, have pushed for access, citing cases where traditional treatments have fallen short.

The administration believes that expediting the process for these treatments is a top priority and a much-needed break from the slower pace of standard drug approval timelines.

However, skepticism remains. Psychedelics can produce strong hallucinogenic effects and carry medical risks, which is why they have remained tightly restricted. Fast-tracking their review does raise some concerns about whether safety standards will be maintained, especially as political pressure builds around delivering results.

How It Affects You

The executive order does not legalize psychedelics, and in most states they are still illegal for recreational use. However, it does change how quickly they will move through the approval pipeline, which is a good start for those seeking treatment from these new methods.

If the process works as intended, patients dealing with PTSD, addiction, or similar conditions could eventually have access to new treatment options through licensed providers. This could be groundbreaking for people who have not responded to existing medications or therapies. It may also influence how insurance providers and healthcare systems approach alternative treatments in the future.

There are still practical and medical hurdles. Even if approved, treatments involving psychedelics would likely require supervision in clinical settings, limiting convenience and increasing costs. For now, the order mainly shows a change in direction at the federal level, with clinical research and trials moving faster into approved, regulated care.

More breaking news below…

Humanoid robot wins Beijing half-marathon while beating world record pace for humans. Read more here…

U.S. and Iranian naval forces stop commercial ships near the Strait of Hormuz, endangering the fragile ceasefire. Read more here…

Some red states are pushing gold as everyday currency, citing inflation concerns, but practical use remains limited, and economists remain skeptical. Read more here…

*Disclaimer: Please read the offering circular and related risks at invest.modemobile.com. This is a paid advertisement for Mode Mobile’s Regulation A+ Offering.

Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.

The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.

Pro forma revenue and EBITDA, includes full year numbers of the businesses acquired throughout 2025.